Overview
Anthem Blue Cross and Blue Shield: Quality-In-Sights®: Hospital Incentive Program (Q-HIP)®
Registration is closed for this activity.
This activity is intended for Blue physicians, pharmacists, nurses, case managers and other healthcare professionals interested in the exchange of medical and pharmacy management information.
This educational activity will help Plans deliver more value to their members and accounts.
Upon completion of this activity, participants will be able to:
- Describe how the alignment of financial incentives for practicing evidence-based medicine and implementing other best practices can lead to improved patient safety and healthcare quality.
- Outline the metrics used in Q-HIP® to measure practice and implementation of industry recognized best practices
- Restate the value of the National Advisory Panel (NAP) providing feedback and advice throughout the year.
- Apply concepts and strategies from the Quality-In-Sights®: Hospital Incentive Program (Q-HIP)® to patient safety efforts at local Plans.
Attendance is restricted to Blue Cross Plan Associates. For further information, please contact Nancy Hitzschke at 312-297-5628.
This activity is jointly sponsored by The Academy for Continued Healthcare Learning and Blue Cross Blue Shield Association
Lindsey Gilbert
Regional Vice President, Enterprise Performance Management
Anthem Blue Cross and Blue Shield of Virginia
Robert Krebbs
Program Director
Anthem Blue Cross and Blue Shield of Virginia
Regional Vice President, Enterprise Performance Management
Anthem Blue Cross and Blue Shield of Virginia
Robert Krebbs
Program Director
Anthem Blue Cross and Blue Shield of Virginia
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. Conflict
resolution must occur prior to the CME/CE activity. The ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. The ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. The provider’s documentation of common practices that make the disclosure requirement known to faculty demonstrates compliance with ACCME guidelines.
Lindsey Gilbert, (Faculty) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Robert Krebbs(Faculty) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Reed Melton, MBA, (Moderator) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Mary Kay Dudley, JD (Planning Committee) Type of financial relationship(s): None
Nancy Hitzschke, MBA, (Planning Committee) Type of financial relationship(s): None
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. The ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. The provider’s documentation of common practices that make the disclosure requirement known to faculty demonstrates compliance with ACCME guidelines.
Lindsey Gilbert, (Faculty) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Robert Krebbs(Faculty) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Reed Melton, MBA, (Moderator) Type of financial relationship(s): None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Mary Kay Dudley, JD (Planning Committee) Type of financial relationship(s): None
Nancy Hitzschke, MBA, (Planning Committee) Type of financial relationship(s): None
The Academy for Continued Healthcare Learning and Blue Cross Blue Shield Association staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This webinar will consist of a moderated lecture with collateral slides and an interactive question and answer session. To request credit or a certificate of participation, participants are required to participate in the webinar, then visit www.accessCME.org at the
conclusion of the activity. After logging in, click “Get Certificate” (in the upper left-hand corner), enter the certificate code provided at the end of the webinar, check to certify you have attended this activity, and complete the evaluation form. You will receive an automated certificate. You may print or save this record for your files. It will also be sent to you via e-mail to the address provided in your profile on www.accessCME.org. There is no fee to participate in the program or for the generation of the certificate.
Accreditation is provided by The Academy for Continued Healthcare Learning (ACHL).
 |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council
for Continuing Medical Education through the joint sponsorship of The Academy for Continued Healthcare Learning and the Blue Cross
Blue Shield Association. The Academy for Continued Healthcare Learning is accredited by the ACCME to provide continuing medical education for physicians. The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
 |
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. In order to receive credit, pharmacists must complete the activity requirements and evaluation at the conclusion of the program. This activity has been approved for a maximum of
0.15 CEU. ACPE Universal Activity Number (UAN): 0396-9999-11-036-L05-P. Activity Type(s): Knowledge Release Date: 7/26/11
|
|
The Academy for Continued Healthcare Learning (ACHL) has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102; (703) 506-3275. In obtaining this approval, The ACHL has demonstrated that it complies with the ANSI/IACET 1-2007 Standard which is recognized internationally as a standard of good practice. As a result of their Authorized Provider membership status, The ACHL is authorized to offer IACET CEUs for its programs that qualify under the ANSI/IACET 1-2007 Standard. The ACHL is authorized by IACET to offer
0.2 CEUs for this activity. CEUs may be used toward nursing credits. Contact your licensing agency for details.
|
|
This program has been pre-approved for 1.5 CEUs by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). Sponsor Code: CM1541 Approval #: 790001351
|
